<DOC>
	<DOCNO>NCT02092298</DOCNO>
	<brief_summary>The goal clinical research study learn hyperthermic intraperitoneal chemotherapy ( HIPEC ) help control disease patient Stage 4 stomach gastroesophageal cancer . The safety treatment also study .</brief_summary>
	<brief_title>Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion ( HIPEC ) Metastatic Gastric Cancer</brief_title>
	<detailed_description>HIPEC Treatment : If find eligible take part study , day HIPEC treatment , receive heat mitomycin-C cisplatin liquid inject 3 4 small incision abdomen 1 hour . This do surgical procedure , general anesthesia . The chemotherapy flush abdomen collect , treatment area inside abdomen wash . Also HIPEC procedure , fluid collect checked cancer cell . As standard care , lesion find treatment may also biopsied time , study doctor think necessary . You may receive 5 HIPEC treatment study . You also receive sodium thiosulfate vein 20 minute protect kidney . You remain hospital 3-7 day treatment . While hospital surgery : - Blood ( 2-3 tablespoon ) may draw routine test , study doctor think necessary . Study Visits : One ( 1 ) time Weeks 2-6 : - You physical exam . - Blood ( 2-3 tablespoon ) draw routine test . Gastrectomy Surgery : If doctor think need , standard care surgery . You receive separate consent form explain surgery risk . On 8 week surgery : - You physical exam . - Blood ( 2-3 tablespoon ) draw routine test . Follow-Up Visits : You routine clinic visit every 6 month date last surgery . You ask cancer treatment may receive . If stop study early , study doctor may ask return office extra CT scan , PET scan , MRIs follow-up period . You CT scan , PET scan , MRI chest , abdomen , pelvis every 6 month 5 year surgery check status disease . Length Study Participation : You study 5 year last surgery . You take study early disease get bad , intolerable side effect occur , unable follow study direction . Your participation study follow-up visit . This investigational study . The chemotherapy surgery standard treatment stomach gastroesophageal cancer . It investigational give chemotherapy HIPEC . Up 30 participant take part study . All enrol MD Anderson .</detailed_description>
	<mesh_term>Gastrointestinal Neoplasms</mesh_term>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Mitomycin</mesh_term>
	<mesh_term>Mitomycins</mesh_term>
	<mesh_term>Sodium thiosulfate</mesh_term>
	<criteria>1 . Age 18 year . There upper age restriction . 2 . Eastern Cooperative Oncology Group ( ECOG ) performance status &lt; /= 2 . 3 . Cytologic histologic proof adenocarcinoma stomach gastroesophageal junction . 4 . Adequate renal , bone marrow function : a. Leukocytes &gt; /= 3,000/microL ; b . Absolute neutrophil count &gt; /= 1,500/microL ; c. Platelets &gt; /= 100,000/Ul ; d. Serum creatinine &lt; /= 1.5 mg/dL . 5 . Hepatic function : AST ( SGOT ) /ALT ( SGPT ) &lt; /= 5 X institutional ( Upper Limit Normal ) ULN . 6 . Distant Metastatic Disease limit peritoneum radiologically occult ( visualized preoperative image include [ Computerized Tomography ] CT scan , Ultrasound , [ Magnetic Resonance Imaging ] MRI , PET/CT ) : . Positive peritoneal cytology ; b. Carcinomatosis diagnostic laparoscopy laparotomy . 7 . Completion preoperative systemic chemotherapy . 1 . Distant metastatic disease limit peritoneum : . Solid organ metastasis ( liver , central nervous system , lung ) . 2 . Any distant metastatic disease visualize preoperative imaging : . Solid organ metastasis ; b . Clear radiologic evidence carcinomatosis . 3 . Infections pneumonia wound infection would preclude protocol therapy . 4 . Women positive urine serum pregnancy test exclude study ; woman childbearing potential ( define undergone hysterectomy postmenopausal least 24 consecutive month ) must agree refrain breast feed practice adequate contraception specify informed consent . Adequate contraception consist oral contraceptive , implantable contraceptive , injectable contraceptive , double barrier method , abstinence . 5 . Subjects unstable angina New York Heart Association Grade II great congestive heart failure . 6 . Subjects deem unable comply study and/or followup procedure . 7 . Subjects know hypersensitivity protocol systemic chemotherapy lifethreatening , require hospitalization prolongation exist hospitalization , result persistent significant disability incapacity .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Gastrointestinal cancer</keyword>
	<keyword>Hyperthermic Intraperitoneal Chemoperfusion</keyword>
	<keyword>HIPEC</keyword>
	<keyword>Gastric carcinomatosis</keyword>
	<keyword>Gastroesophageal cancer</keyword>
	<keyword>Mitomycin C</keyword>
	<keyword>Mitomycin</keyword>
	<keyword>Cisplatin</keyword>
	<keyword>Platinol-AQ</keyword>
	<keyword>Platinol</keyword>
	<keyword>CDDP</keyword>
	<keyword>Sodium Thiosulfate</keyword>
	<keyword>Tinver</keyword>
</DOC>